anticancer agents (China Medical University)

N/A

Report date: 2025/03/18 18:05:33
NME

Base Information

Drug Nameanticancer agents (China Medical University)
Drug Alias Namepoly ADP ribose polymerase 1 inhibitor (China Medical University)PARP1 inhibitors (China Medical University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 inhibitors
TargetsPoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Medical University, China
China Registration ClassN/A

Develop Information

Active CompaniesChina Medical University, China
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A